EXCITOTOXIN EFFECTS ON SPINAL CORD IN VITRO
体外兴奋毒素对脊髓的影响
基本信息
- 批准号:3414065
- 负责人:
- 金额:$ 14.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-04-01 至 1993-03-31
- 项目状态:已结题
- 来源:
- 关键词:acetylcholinesterase aspartate cholinergic receptors degenerative motor system disease dosage excitatory aminoacid glutamate receptor histochemistry /cytochemistry inhibitor /antagonist kynurenate laboratory rat lactate dehydrogenases neural degeneration neurotoxins neurotransmitter receptor somatostatin spinal cord stimulant /agonist synapses tissue /cell culture
项目摘要
Excitatory amino acids (EAAs) acting at specific membrane receptors may
promote neuron degeneration or death in many nervous system diseases and
have been specifically implicated in pathogenesis of motor neuron diseases.
EAA-mediated damage to anatomically and histochemically defined neurons can
be examined in organotypic roller tube cultures of postnatal rat spinal
cord (OTC-SCs). Our studies show damage to ventral and dorsal horns in
OTC-SCs by the excitotoxin, N-methyl-D-aspartic acid (NMDA). This projects
examines actions of NMDA and other EAA agonists on cholinergic markers in
spinal cord in vitro using the OTC-SC system.
First, OTC-SCs will be treated with NMDA, with or without specific
antagonists. Damage to spinal cord cholinergic systems will be assessed by
histological and morphometric analysis after staining cultures for
acetylcholinesterase activity (AChE) and choline acetyltransferase (CHAT) -
immunoreactivity, and by biochemical analysis of ACHE and CHAT activities.
Lactate dehydrogenase efflux from cultures will be examined to obtain an
overall assessment of neuronal damage. Next, dose-response curves and
temporal aspects of the effects will be determined.
Third, cultures will be treated with the EAA agonists, kainic acid or
quisqualic acid. Using specific NMDA-receptor antagonists or non-NMDA-
receptor antagonists, the extent to which damage is mediated through
different EAA receptor subtypes will be determined.
In OTC-SCs, damage by L-glutamate compared with kainate or NMDA is less
than in many culture systems, reflecting more closely its effect in vivo.
Therefore, the fourth specific aim is to investigate two possible
mechanisms for the decreased effect of glutamate: the role of glutamate
uptake and the role of kynurenic acid as an endogenous EAA antagonist.
Fifth, we will determine whether a potent somatostatin analogue, SMS 201-
995, can alter the toxic effects of NMDA, L-glutamate, or other
excitotoxins on neurons in OTC-SCs.
The long-term objective of this research is to understand better the role
of excitotoxins in spinal neuron degeneration and death.
作用于特定膜受体的兴奋性氨基酸(EaAs)可能
在许多神经系统疾病中促进神经元退化或死亡
已明确与运动神经元疾病的发病机制有关。
EAA介导的解剖学和组织化学定义的神经元损伤可以
出生后大鼠脊髓器官型滚管培养中的检测
电源线(OTC-SCS)。我们的研究显示腹角和背角在
OTC-SCs由兴奋性毒素N-甲基-D-天冬氨酸(NMDA)诱导。这个项目
检测NMDA和其他EAA激动剂对胆碱能标记物的作用
采用OTC-SC系统进行脊髓体外培养。
首先,OTC-SCs将接受NMDA治疗,无论是否有特定的
对抗者。脊髓胆碱能系统的损害将通过以下方法进行评估
培养物染色后的组织学和形态计量学分析
乙酰胆碱酯酶活力(AChE)和胆碱乙酰转移酶(ChAT)-
免疫反应性,AChE和ChAT活性的生化分析。
从培养物中排出的乳酸脱氢酶将被检测以获得
对神经元损伤进行全面评估。接下来,剂量-反应曲线和
影响的时间方面将被确定。
第三,培养物将用EAA激动剂、红藻氨酸或
准奎奎酸。使用特定的NMDA受体拮抗剂或非NMDA-
受体拮抗剂,损伤的程度是通过
不同的EAA受体亚型将被确定。
在OTC-SCs中,L-谷氨酸的损伤比红藻氨酸或N-甲基-D-天冬氨酸要小
比在许多培养系统中更能反映其在体内的作用。
因此,第四个具体目标是调查两种可能的
谷氨酸作用减弱的机制:谷氨酸的作用
犬尿酸作为内源性EAA拮抗剂的摄取和作用。
第五,我们将确定一种强有力的生长抑素类似物,SMS201-
可以改变N-甲基-D-天冬氨酸、L-谷氨酸等的毒性作用
兴奋性毒素对OTC-SCs神经元的影响。
这项研究的长期目标是更好地理解
兴奋性毒素在脊髓神经元退化和死亡中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN R DELFS其他文献
JOHN R DELFS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN R DELFS', 18)}}的其他基金
PHYSIOLOGY AND PHARMACOLOGY OF CORTICAL NEUROPEPTIDES
皮质神经肽的生理学和药理学
- 批准号:
3078236 - 财政年份:1983
- 资助金额:
$ 14.98万 - 项目类别:
相似国自然基金
固本祛湿化瘀方调控银屑病角质细胞与初始T细胞Aspartate交互的机制研究
- 批准号:82305246
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Balancing redox homeostasis and the metabolic network through metabolite compartmentalisation: SLC25A13, aspartate, and the mitochondrion
通过代谢物区室平衡氧化还原稳态和代谢网络:SLC25A13、天冬氨酸和线粒体
- 批准号:
BB/Y002865/1 - 财政年份:2023
- 资助金额:
$ 14.98万 - 项目类别:
Research Grant
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 14.98万 - 项目类别:
Regulation of brown fat fuel utilization by the malate-aspartate shuttle
苹果酸-天冬氨酸穿梭对棕色脂肪燃料利用的调节
- 批准号:
10712090 - 财政年份:2023
- 资助金额:
$ 14.98万 - 项目类别:
The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells
苹果酸-天冬氨酸穿梭将膳食脂肪酸与树突状细胞的炎症反应联系起来
- 批准号:
10772912 - 财政年份:2023
- 资助金额:
$ 14.98万 - 项目类别:
L-Aspartate signalling in the brain
大脑中的 L-天冬氨酸信号传导
- 批准号:
MR/W028964/1 - 财政年份:2022
- 资助金额:
$ 14.98万 - 项目类别:
Research Grant
The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells
苹果酸-天冬氨酸穿梭将膳食脂肪酸与树突状细胞的炎症反应联系起来
- 批准号:
10528235 - 财政年份:2022
- 资助金额:
$ 14.98万 - 项目类别:
Manipulating N-acetyl-L-aspartate transport to treat Canavan leukodystrophy
操纵 N-乙酰基-L-天冬氨酸转运来治疗 Canavan 脑白质营养不良
- 批准号:
10406711 - 财政年份:2022
- 资助金额:
$ 14.98万 - 项目类别:
Manipulating N-acetyl-L-aspartate transport to treat Canavan leukodystrophy
操纵 N-乙酰基-L-天冬氨酸转运来治疗 Canavan 脑白质营养不良
- 批准号:
10554428 - 财政年份:2022
- 资助金额:
$ 14.98万 - 项目类别:
Role of altered endoplasmic reticulum calcium regulation and the N-methyl-D-aspartate (NMDA) receptor signaling in cortico-striatal synaptic dysfunction: Opportunities for therapy in prodromal Huntington disease
改变的内质网钙调节和 N-甲基-D-天冬氨酸 (NMDA) 受体信号在皮质纹状体突触功能障碍中的作用:前驱期亨廷顿病的治疗机会
- 批准号:
443591 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别:
Operating Grants
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
一项 2b 期、双盲、随机对照试验,旨在评估 Inebilizumab 在抗 N-甲基-D-天冬氨酸受体 (NMDAR) 脑炎中的活性和安全性并评估疾病标志物
- 批准号:
10185824 - 财政年份:2021
- 资助金额:
$ 14.98万 - 项目类别:














{{item.name}}会员




